Clinical Trials Sponsored by FRANCE ALZHEIMER

Total 5906 results

University Hospital, Lille
France Alzheimer

Not yet recruiting

Social & Affective Cognition in Alzheimer's Disease & Associated Disorders (SOCIALIZE)

Alzheimer's Disease | Frontotemporal Degeneration (Semantic & Behavioral Variants)
University Hospital, Toulouse
France Alzheimer

Recruiting

Cohort of Patients With Alzheimer's Disease and Their Families. (ALFA3pilot)

Alzheimer Disease

France
University Hospital, Lille
France Alzheimer

Unknown

Nonverbal Communication in Aged People (MAMUS)

Alzheimer Disease

France
Assistance Publique - Hôpitaux de Paris
France Alzheimer

Recruiting

The Ketogenic Diet for Alzheimer's Disease (CETOMA)

Alzheimer Disease, Early Onset

France
Assistance Publique - Hôpitaux de Paris
France Alzheimer

Recruiting

Donepezil Versus Non-drug Treatment in Alzheimer's Disease. (CHOLINE-2)

Alzheimer Disease, Early Onset

France
Institut National de la Santé Et de la Recherche...
France Alzheimer

Not yet recruiting

MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A PET/MR STUDY (PET-AL)

Alzheimer Disease, Early Onset | Posterior Cortical Atrophy

France
Central Hospital, Nancy, France
France Alzheimer; Laboratoire APEMAC :Maladies chroniques, santé perçue, processus...

Unknown

Memory Problems Perceptions Among Patients and Accompaniers During Diagnosis Process : (REMAD)

Alzheimer Disease | Memory Disorders

France
Hearthstone Alzheimer Care
Abbott

Unknown

Study of Depakote for Behavioral and Psychological Symptoms in Dementia

Dementia

United States
Innovation Alzheimer
Centre Hospitalier Universitaire de Nice; Alzheimer's Association; Université...

Completed

Efficacy of the Memory Motivation (MEMO) Web Application Training (MeMo)

Neurocognitive Disorders

France
Hasselt University
Stichting Alzheimer Onderzoek

Recruiting

Adherence by Music to Exercise in Dementia: Group Therapy (AMUSED)

Dementia

Belgium
Dalhousie University
Alzheimer Society of Canada

Not yet recruiting

Dementia Moves: Protocol for a Feasibility Study

Moderate to Severe Dementia
McMaster University
Alzheimer Society of Canada

Completed

Supporting Caregivers of Persons With Dementia: A Pilot Study

Dementia | Alzheimer Disease

Canada
JANSSEN Alzheimer Immunotherapy Research & Development...

Terminated

AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
Central Hospital, Nancy, France
French Cardiology Society

Completed

Relationship Between Thoracic Aortic Structure Assessed B PET/CT Scan and Arterial Stiffness in Elderly Patients (FICTEP)

Inflammation | Aging

France
Vaccinex Inc.
Alzheimer's Association; Alzheimer's Drug Discovery Foundation

Active, not recruiting

SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD) (SIGNAL-AD)

Alzheimer Disease

United States
University Hospital, Strasbourg, France
Sanofi; French State

Unknown

Thromboprophylaxis and Bariatric Surgery

Thromboembolism

France
Baycrest
Alzheimer's Society

Not yet recruiting

Investigating if a Stronger tDCS Intensity is More Effective for Improving Naming Ability in People Living With Alzheimer's Disease

Alzheimer Disease

Canada
University Hospital, Toulouse
Fondation Plan Alzheimer

Completed

Effect of Neflamapimod on Brain Inflammation in Alzheimer's Disease Patients (VIP)

Alzheimer Disease

France
University Hospital, Bordeaux
Fondation Plan Alzheimer

Completed

A Cohort of Outpatients From French Research Memory Centers in Order to Improve Knowledge on Alzheimer's Disease and Related Disorders (MEMENTO)

Alzheimer's Disease (AD) and Related Disorders

France
Lakehead University
Alzheimer Society of Canada

Completed

Mindfulness Research Program: Designed to Enhance Wellbeing in People Living With Dementia and Their Spouses (MBCT_AD)

Dementia
Leiden University Medical Center
Alzheimer Nederland

Recruiting

WHIte MAtter Hyperintensity Shape and Glymphatics (WHIMAS)

Cognitive Impairment | Mild Cognitive Impairment | Cerebral Small Vessel Diseases | Dementia, Vascular | Cognitive Decline | Dementia, Mixed

Netherlands
Fundacion CITA-alzheimer
Biogipuzkoa Health Research Institute

Completed

GOIZ ZAINDU Feasibility Multi Domain Trial to Prevent Dementia. (GOIZ_ZAINDU)

Cognitive Decline | Prevention | Dementia Risk Factors | Multidomain Intervention

Spain
Charite University, Berlin, Germany
German Alzheimer Society

Completed

Validation and Optimization of the Individual Benefits of Locating Systems in Dementia Care (VODINO)

Dementia

Germany
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Terminated

Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab

Alzheimer Disease

United States
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Alzheimer Disease

United States
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

Alzheimer's Disease

Japan
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease

Alzheimer Disease

Japan
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Terminated

Retrieval of Patient Information After Discontinuation (RAPID)

Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Completed

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease (ACCTION)

Alzheimer's Disease

United States
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Completed

Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease (SUMMIT AD)

Alzheimer's Disease

United States
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Terminated

A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States, Canada, Austria
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Completed

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)

Alzheimer's Disease

United States, Germany, Canada, Austria
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Completed

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)

Alzheimer's Disease

United States
Amylyx Pharmaceuticals Inc.
Alzheimer's Association; Alzheimer's Drug Discovery Foundation

Completed

Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease (PEGASUS)

Alzheimer Disease

United States
Central Hospital, Nancy, France
Ministry of Health, France; Boehringer Ingelheim; French Cardiology Society

Completed

Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population (PARTAGE)

Hypertension | Cognitive Impairment | Elderly | Morbidity | Cardiovascular Mortality

France, Italy
Alzheimer's Light LLC

Recruiting

Longitudinal Cognitive Assessment by BoCA (BoCA)

Multiple Sclerosis | Parkinson Disease | Alzheimer Disease | Mild Cognitive Impairment | Frontotemporal Dementia | Vascular Dementia | TBI

United States
Kinto
Alzheimer's Association

Completed

Efficacy Study of Kinto Care Coaching for Dementia Family Caregivers

Dementia | Alzheimer Disease | Lewy Body Disease | Frontotemporal Dementia | Vascular Dementia | Mixed Dementia

United States
Alzheimer's Light LLC

Recruiting

Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy (AlzLife)

Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognition Disorders in Old Age

United States
Korean Alzheimers' Disease Neuroimaing Intitiative

Unknown

Korea Alzheimer's Disease Neuroimaging Initiative (K-ADNI)

Mild Cognitive Impairment | Alzheimer's Disease | Subcortical Vascular Dementia

Korea, Republic of
Fondation Mederic Alzheimer
Malakoff-Humanis; Siel Bleu

Completed

Gentle Gymnastics and Relationship Between Family Caregivers and Residents With Dementia in Nursing Homes

Dementia | Relation, Family

France
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Alzheimer Disease

Spain, France, Germany
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Korea, Republic of, United States
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

Alzheimer's Disease

United States
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Terminated

Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

Alzheimer's Disease

Japan
Maastricht University Medical Center
Netherlands Alzheimer Foundation

Unknown

Blood-brain Barrier Leakage in Dementia. A Dynamic Contrast-enhanced MRI Study

Vascular Dementia | Alzheimer's Disease
University Hospital, Aachen
Alzheimer Forschung Initiative e.V.

Completed

Therapy of Alzheimer's Disease With Neurofeedback

Elderly | Alzheimer Dementia (AD)
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease

Alzheimer's Disease

United States, Korea, Republic of
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Terminated

A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease

Alzheimer Disease

United States
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Completed

AAB-001 in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
Radboud University Medical Center
Netherlands Alzheimer Foundation

Completed

Support Groups for Patients With Mild Cognitive Impairment and Their Partners

Mild Cognitive Impairment

Netherlands

Clinical Trials Sponsored by FRANCE ALZHEIMER

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations